Moderately to severely active ulcerative colitis
The purpose of this study is to learn about the safety and effectiveness of an investigational drug called Guselkumab in the treatment of ulcerative colitis. Guselkumab has already been approved by the TGA for the treatment of other inflammatory conditions, and this study aims to learn if it is effective in the treatment of ulcerative colitis as well.